Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market Focus on Developing New HPV and CMV therapeutics
Human papillomavirus (HPV) is a viral pathogens. It is a different than Herpes Simplex Virus (HSV) and Human Immunodeficiency Virus (HIV). HPV is a major cause of throat, mouth, anus, penis, vagina, vulva, and cervical cancer. Various strains of HPV plays an important role in causing most cervical cancer. Cytomegalovirus (CMV) is also a viral pathogens and is the most common herpesvirus infection. It can spread through both sexual and non-sexual contact with body fluids, such as urine, breast milk, semen, and saliva. Symptoms may include fatigue, diarrhea, fever, hepatitis, pneumonia, shortness of breath, and gastrointestinal ulceration.
Growth of the human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market is mainly driven by the increasing number of sexually transmitted infections. According to World Health Organization’s (WHO) 2019 report, each year, more than 290 million women suffer from HPV infection worldwide, and every day, more than one million people suffer from sexually transmitted infections (STIs) worldwide. Thus, with increasing number of STIs, the demand for HPV and CMV therapeutics is also increasing, which, in turn, driving the human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market growth.
In October 2020, HOOKIPA Pharma Inc. announced the first patient dosed with HB-202, a replicating arenavirus therapy based on the Pichinde Virus. HB-202 is part of a sequential alternating regimen of HB-202/HB-201 for the treatment of Human Papillomavirus 16-positive (HPV16+) cancers in the ongoing HB-201 Phase 1/2 trial (NCT04180215). Moreover, in 2018, Merck & Co., Inc. received the United States Food and Drug Administration (FDA) approval for Gardasil 9 (HPV 9-valent vaccine) for the treatment of certain diseases caused by HPV. Gardasil 9 is used for vaginal, vulvar, cervical, and anal cancers caused by HPV.
Moreover, the human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market is witnessing substantial growth due to increasing incidence of cervical cancer and initiatives by health regulatory authorities for the treatment of cervical cancer. According to the WHO, cervical cancer is the fourth most common cancer in women. In 2018, an estimated 570,000 women were diagnosed with cervical cancer worldwide and about 311,000 women died from the disease. Moreover, in November 2020, WHO launched a global initiative to accelerate the elimination of cervical cancer, and set up an historical milestone that pledged to eliminate a malignant disease by pursuing three important steps: screening, treatment, and vaccination.
In October 2019, Kenya launched a mass vaccination of girls against the human papillomavirus (HPV), which can lead to cervical cancer.
Natural herbs have treated so many illnesses that drugs and injections can't treat. I've seen the great importance of natural herbs and the wonderful work they have done in people's lives. I read people's testimonies online on how they were treated of HSV, HPV, Herpes, Liver diseases, Anxiety, Fever ,diarrhoea, aches and pains, sore throat , etc , by natural medicine, so I decided to contact the Naturopath Dr because I know nature has the power to heal anything. Believe it or not. but I am a living testimony. There is no harm trying natural herbs. Contact Dr on, text/call via: +1 (719) 629 0982 ,For herbs and medications. Or you can also contact through his Facebook page @ Dr Chike Herbal Remedy.
ReplyDelete